Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M58.5Revenue $M15.2Net Margin (%)-95.2Altman Z-Score-3.0
Enterprise Value $M17.0EPS $-0.2Operating Margin %-96.0Piotroski F-Score5
P/E(ttm)--Beneish M-Score-2.9Pre-tax Margin (%)-95.2Higher ROA y-yY
Price/Book1.210-y EBITDA Growth Rate %-17.6Quick Ratio11.6Cash flow > EarningsY
Price/Sales3.45-y EBITDA Growth Rate %-15.0Current Ratio11.6Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-28.2Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-30.9Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M91.4ROIC % (ttm)-181.8Gross Margin Increase y-yY

Gurus Latest Trades with VICL

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
VICLJohn Rogers 2015-03-31 Add$0.86 - $1.17
($1.02)
$ 0.64-37%Add 7.34%6,958,945
VICLGeorge Soros 2014-09-30 Sold Out $1.12 - $1.31
($1.24)
$ 0.64-48%Sold Out0
VICLGeorge Soros 2014-06-30 Buy $1.12 - $1.35
($1.19)
$ 0.64-46%New holding58,179
VICLJohn Rogers 2013-12-31 Add0.03%$1.015 - $1.49
($1.2)
$ 0.64-47%Add 39.31%7,062,104
VICLJohn Rogers 2013-06-30 Add0.13%$2.93 - $4.22
($3.52)
$ 0.64-82%Add 93.26%5,134,817
VICLJohn Rogers 2013-03-31 Add0.08%$2.91 - $4.26
($3.54)
$ 0.64-82%Add 71.60%2,656,967
VICLJohn Rogers 2012-12-31 Add0.03%$2.74 - $4.32
($3.31)
$ 0.64-81%Add 49.50%1,548,357
VICLJohn Rogers 2012-03-31 Add0.01%$3.02 - $4.28
($3.23)
$ 0.64-80%Add 26.34%877,193
VICLJohn Rogers 2011-06-30 Reduce-0.01%$2.88 - $4.81
($3.75)
$ 0.64-83%Reduce 30.97%577,773
VICLJohn Rogers 2010-09-30 Add0.03%$2.21 - $3.86
($3.2)
$ 0.64-80%Add 548.18%795,728
VICLJohn Rogers 2009-06-30 Buy 0.01%$1.95 - $2.76
($2.28)
$ 0.64-72%New holding137,198
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

VICL is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


VICL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Ramos Anthony AlanVP, Chief Accounting Officer 2015-07-23Sell194$0.623.23view
SMITH LAWRENCE RUSSELLVP, Vaccine Research 2015-07-13Sell974$0.7-8.57view
SAMANT VIJAY BPresident & CEO 2015-07-13Sell4,737$0.7-8.57view
BILINSKY IGORSr VP, Corporate Development 2015-07-13Sell1,258$0.7-8.57view
Ramos Anthony AlanVP, Chief Accounting Officer 2015-04-23Sell193$1.01-36.63view
SMITH LAWRENCE RUSSELLVP, Vaccine Research 2015-04-13Sell974$0.93-31.18view
BILINSKY IGORSr VP, Corporate Development 2015-04-13Sell1,257$0.93-31.18view
SAMANT VIJAY BPresident & CEO 2015-04-13Sell4,738$0.93-31.18view
SAMANT VIJAY BPresident & CEO 2015-03-30Sell55,000$0.91-29.67view
Ramos Anthony AlanVP, Chief Accounting Officer 2015-01-21Sell428$1.09-41.28view

Quarterly/Annual Reports about VICL:

News about VICL:

Articles On GuruFocus.com
Red Hat (RHT) and Five Below (FIVE) Strong Performance Metrics; Vical (VICL) Targets Multi-billion S Mar 26 2015 
John Rogers Comments on Vical Feb 26 2014 
Kids Decide on Dolls or Devices - JAKK, Others 70% Off Sep 17 2013 
comment on VICL Mar 02 2013 
Weekly CFO Buys Highlight: VICL, EXA, UCBA, YORW, MGI Jan 21 2013 
Vical Inc. Insiders Boost Shares after Company’s NASDAQ Listing Gets Upgrade Jan 17 2013 
Two Biotech Stocks to Buy, One to Avoid Jan 09 2012 
Vical Inc. (VICL) CEO Vijay B Samant buys 1,000 Shares Jan 20 2011 
Vical Inc. Reports Operating Results (10-Q) Aug 06 2010 
Vical Inc. Reports Operating Results (10-Q) May 07 2010 

More From Other Websites
Vical Announces News Release and Conference Call Schedule for Second Quarter 2015 Financial Results Jul 23 2015
Vical Announces News Release and Conference Call Schedule for Second Quarter 2015 Financial Results Jul 23 2015
The Zacks Analyst Blog Highlights: BioMarin, Vical, Epizyme, Amgen and Medicines Co - Press Releases Jun 25 2015
Biotech Stock Roundup: BioMarin Jumps on Dwarfism Data, Vical Plunges on Vaccine Data - Analyst Blog Jun 24 2015
Vical Looks a Lot Less Vital Jun 24 2015
Vical downgraded by ROTH Capital Jun 23 2015
Vical's Herpes Vaccine Didn't Meet Primary Endpoint Jun 22 2015
Vical Reports Top-Line Results From Phase 1/2 Trial of Therapeutic Genital Herpes Vaccine Jun 22 2015
VICAL INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jun 22 2015
Vical Reports Top-Line Results From Phase 1/2 Trial of Therapeutic Genital Herpes Vaccine Jun 22 2015
Can the Uptrend Continue for Vical (VICL)? - Tale of the Tape Jun 10 2015
Vical (VICL) Stock Jumps on Positive Coverage Initiation Jun 02 2015
VICAL INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 26 2015
Vical Announces Completion of Enrollment in Phase 2 Clinical Trial of Investigational CMV Vaccine in... May 21 2015
Vical Announces Completion of Enrollment in Phase 2 Clinical Trial of Investigational CMV Vaccine in... May 21 2015
VICAL INC Financials May 20 2015
Vical Q1 Loss Narrower than Expected, Pipeline in Focus - Analyst Blog May 11 2015
10-Q for Vical, Inc. May 10 2015
VICAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... May 08 2015
Q1 2015 Vical Inc Earnings Release - Before Market Open May 08 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK